771 – 780 of 1390
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases
(
- Contribution to journal › Article
-
Mark
Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease.
(
- Contribution to journal › Article
-
Mark
Korsallergi mellan penicilliner och övriga betalaktam-antibiotika - Risken är betydligt mindre än man tidigare trott.
(
- Contribution to journal › Article
-
Mark
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
(
- Contribution to journal › Article
-
Mark
Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
(
- Contribution to journal › Article
-
Mark
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).
(
- Contribution to journal › Article
-
Mark
Anti-endotoxic and antibacterial effects of a dermal substitute coated with host defense peptides.
(
- Contribution to journal › Article
-
Mark
Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units
(
- Contribution to journal › Article
-
Mark
Chronic Obstructive Pulmonary Disease Is Common in Never-smoking Patients with Primary Sjögren Syndrome.
(
- Contribution to journal › Article
-
Mark
The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
(
- Contribution to journal › Article